4
Changes in Ownership
ACADIA PHARMACEUTICALS INC Filed Acc 0001209191-23-002900
CEO sold 3,904 shares at $17.13 ($66,877)
- CEO acquired 9,528 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| DAVIS STEPHEN CEO | 2023-01-06 | Option exercise | +9,528 | 88,537 | D | ||
| DAVIS STEPHEN CEO | 2023-01-09 | Sale | −3,904 | $17.13 | $66,877 | 84,633 | D |
| Derivatives | |||||||
| DAVIS STEPHEN CEO | 2023-01-06 | Option exercise · Restricted Stock Units | −9,528 | 9,528 | D | ||
| Open-market sales · 3,904 sh · avg $17.13 · $66,877 | |||||||
Loading xslF345X03/doc4.xml…